Ken Griffin Hires Two Moore Capital Veterans for Macro Expansion (Bloomberg)
Billionaire Ken Griffin hired two veteran money managers from Louis Bacon’s hedge fund as he seeks to build a rival macro business. Marco Birch and Eric Dannheim will join Griffin’s $30 billion Citadel later this year as senior portfolio managers, spokeswoman Julia Kosygina confirmed. They will be part of Citadel’s macro strategies business, which was started in early 2018, and report to group head Colin Lancaster.
Hedge Funds in the Business of Breaking Up Deals See Big Payoff, Study Finds (CNBC)
Turns out, killing deals, or even attempting to do so, can be a profitable business. That’s the thinking behind an increasingly popular tactic for hedge-fund activists – and it seems to be paying off. Carl Icahn recently used it to try to destroy Cigna’s $54 billion purchase of Express Scripts. When reports of Icahn’s plan surfaced on Aug. 1, Cigna’s shares gained about 2 percent, while Express Scripts shares slumped 6.3 percent.
Luis Louro / shutterstock.com
Insider Selling: Howard Hughes Corp (NYSE:HHC) Director Sells 51,660 Shares of Stock (MareaInformativa.com)
Howard Hughes Corp (NYSE:HHC) Director Pershing Square Capital Manage sold 51,660 shares of the business’s stock in a transaction dated Monday, September 24th. The stock was sold at an average price of $126.13, for a total value of $6,515,875.80. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
Insider Buying: Amicus Therapeutics, Inc. (NASDAQ:FOLD) Major Shareholder Buys 500,000 Shares of Stock (XNewsPress.com)
Amicus Therapeutics, Inc. (NASDAQ:FOLD) major shareholder Life Sciences Maste Perceptive purchased 500,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 12th. The stock was acquired at an average price of $12.00 per share, for a total transaction of $6,000,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Insider Selling: Falcon Minerals Corp (FLMN) Major Shareholder Sells 944,703 Shares of Stock (FairFieldCurrent.com)
Falcon Minerals Corp (NASDAQ:FLMN) major shareholder Jana Partners Llc sold 944,703 shares of the business’s stock in a transaction that occurred on Monday, September 24th. The shares were sold at an average price of $11.40, for a total value of $10,769,614.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
Insider Buying: Jerrick Media Holdings Inc (OTCMKTS:JMDA) Major Shareholder Buys 352,700 Shares of Stock (PressOracle.com)
Jerrick Media Holdings Inc (OTCMKTS:JMDA) major shareholder Arthur Rosen bought 352,700 shares of Jerrick Media stock in a transaction that occurred on Tuesday, September 4th. The shares were acquired at an average price of $0.18 per share, with a total value of $63,486.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.
Insider Buying: Apellis Pharmaceuticals Inc (NASDAQ:APLS) Major Shareholder Buys 81,323 Shares of Stock (MareaInformativa.com)
Apellis Pharmaceuticals Inc (NASDAQ:APLS) major shareholder Morningside Venture Investment purchased 81,323 shares of Apellis Pharmaceuticals stock in a transaction dated Friday, September 21st. The stock was bought at an average price of $19.48 per share, for a total transaction of $1,584,172.04. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission.
Insider Selling: Yelp Inc (NYSE:YELP) COO Sells 10,500 Shares of Stock (BaseballDailyDigest.com)
Yelp Inc (NYSE:YELP) COO Joseph R. Nachman sold 10,500 shares of the firm’s stock in a transaction that occurred on Thursday, September 20th. The shares were sold at an average price of $49.77, for a total transaction of $522,585.00. Following the completion of the sale, the chief operating officer now owns 119,935 shares in the company, valued at approximately $5,969,164.95. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
